Literature DB >> 19871573

IMMUNITY IN MUMPS : IV. THE CORRELATION OF THE PRESENCE OF COMPLEMENT-FIXING ANTIBODY AND RESISTANCE TO MUMPS IN HUMAN BEINGS.

E P Maris1, J F Enders, J Stokes, L W Kane.   

Abstract

Of 163 persons giving positive complement fixation tests who were exposed to mumps, 1 afterwards developed the disease; of 285 negative reactors similarly exposed, 56 afterwards came down with mumps. Of 78 individuals subjected to intimate exposure to mumps whose tests were originally negative and who failed to develop the disease, 41 per cent gave positive reactions when tested 1 month later. Seventy-seven per cent of complement fixation tests done on the sera of 565 normal adults who admitted a previous attack of mumps were positive. A similar correlation was recorded in tests on the sera of a small group of children with positive histories. Of 356 medical students admitting previous attacks, 80 per cent gave positive tests. Of 386 normal adults who denied previous attacks, 42 per cent gave positive tests; of 85 children giving negative histories, 38 per cent reacted positively. The results of complement fixation tests on the sera of 1665 normal adults (over 17 years) and 679 children (1 to 17 years) are recorded. It has been shown that 63 per cent of the adults and 57 per cent of the children had antibody in their blood which reacted with the virus of mumps. In groups in which exceptionally intense exposure was not known to have occurred in the past, the proportions of positive reactors were: adults, 61 per cent; children, 49 per cent. In contrast to these normal persons, the incidence of positive reactors among permanently institutionalized mental defectives was 38 per cent of 356 adults and 32 per cent of 475 children. In only 2 per cent of 320 normal adults and children did the titer of complement-fixing antibody reach 1-192. In no instance in which the endpoint was determined was a higher titer recorded. The results of complement fixation tests on the sera of mother and newborn infant were essentially the same in 5 instances.

Entities:  

Keywords:  COMPLEMENT/fixation; IMMUNITY; PAROTITIS/immunity

Mesh:

Substances:

Year:  1946        PMID: 19871573      PMCID: PMC2135631          DOI: 10.1084/jem.84.4.323

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  4 in total

1.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. X. THE CONCENTRATIONS OF CERTAIN ANTIBODIES IN GLOBULIN FRACTIONS DERIVED FROM HUMAN BLOOD PLASMA.

Authors:  J F Enders
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

2.  IMMUNITY IN MUMPS : III. THE COMPLEMENT FIXATION TEST AS AN AID IN THE DIAGNOSIS OF MUMPS MENINGOENCEPHALITIS.

Authors:  L W Kane; J F Enders
Journal:  J Exp Med       Date:  1945-01-01       Impact factor: 14.307

3.  IMMUNITY IN MUMPS : II. THE DEVELOPMENT OF COMPLEMENT-FIXING ANTIBODY AND DERMAL HYPERSENSITIVITY IN HUMAN BEINGS FOLLOWING MUMPS.

Authors:  J F Enders; S Cohen; L W Kane
Journal:  J Exp Med       Date:  1945-01-01       Impact factor: 14.307

4.  IMMUNITY IN MUMPS : I. EXPERIMENTS WITH MONKEYS (MACACUS MULATTA). THE DEVELOPMENT OF COMPLEMENT-FIXING ANTIBODY FOLLOWING INFECTION AND EXPERIMENTS ON IMMUNIZATION BY MEANS OF INACTIVATED VIRUS AND CONVALESCENT HUMAN SERUM.

Authors:  J F Enders; L W Kane; S Cohen; J H Levens
Journal:  J Exp Med       Date:  1945-01-01       Impact factor: 14.307

  4 in total
  8 in total

1.  [Research on the problem of mumps immunity].

Authors:  H LIPPELT; F MULLER
Journal:  Arch Gesamte Virusforsch       Date:  1955

2.  [Virus-caused diseases in otorhinolaryngology].

Authors:  A BECKER
Journal:  Arch Ohren Nasen Kehlkopfheilkd       Date:  1955-05-02

3.  [Experiences on production, evaluation and serodiagnostic application of the complement fixation antigens in mumps].

Authors:  R SIEGERT; H G HAUSSMANN; H SCHWEINSBERG
Journal:  Z Hyg Infektionskr       Date:  1953

4.  Viral Infections of the Human Nervous System: Classification and General Considerations.

Authors:  A B Sabin
Journal:  Postgrad Med J       Date:  1950-03       Impact factor: 2.401

5.  Establishing a small animal model for evaluating protective immunity against mumps virus.

Authors:  Adrian Pickar; Pei Xu; Andrew Elson; James Zengel; Christian Sauder; Steve Rubin; Biao He
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

6.  The reactivity of various human sera with mumps complement fixation antigens.

Authors:  G HENLE; S HARRIS; W HENLE
Journal:  J Exp Med       Date:  1948-07       Impact factor: 14.307

7.  IMMUNITY IN MUMPS : V. THE CORRELATION OF THE PRESENCE OF DERMAL HYPERSENSITIVITY AND RESISTANCE TO MUMPS.

Authors:  J F Enders; L W Kane; E P Maris; J Stokes
Journal:  J Exp Med       Date:  1946-09-30       Impact factor: 14.307

8.  Isolation of mumps virus from human beings with induced apparent or inapparent infections.

Authors:  G HENLE; W HENLE
Journal:  J Exp Med       Date:  1948-08       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.